RFP for Angelman Syndrome Research
The Angelman Syndrome Foundation has issued an RFP for AS-related research projects. One- and two-year grants of up to $100,000 per year will be awarded under this RFP, with priority given to projects focused on studying or correcting the heterozygous effect of non-UBE3A genes in deletion; the potential results of increasing UBE3A after therapies or for some subtypes of AS; the delivery of therapies and potential for improvement; and symptomatic therapies that impact the daily life of people with Angelman syndrome and their families.
For complete program guidelines, information about previously funded projects, and application instructions, see the Angelman Syndrome Foundation website.
Submissions to this sponsor/donor are managed by the Office of Corporate and Foundation Relations. Please contact your unit-assigned ASUF Director of Development or Research Advancement Specialist at your earliest convenience to ensure ASU's strategic coordination and management of funding applications.